ProfileGDS4718 / 228069_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 71% 37% 12% 62% 52% 87% 84% 62% 52% 66% 64% 55% 81% 85% 87% 69% 59% 89% 81% 74% 61% 64% 67% 67% 78% 76% 58% 72% 61% 84% 72% 75% 37% 58% 74% 80% 87% 44% 52% 7% 61% 86% 53% 84% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.9856171
GSM549102patient 115, normal, homogenized [OPG study]4.851637
GSM549104patient 119, normal, homogenized [OPG study]3.8417512
GSM549108patient 138, normal, homogenized [OPG study]6.2954662
GSM549119patient 077, normal, homogenized [OPG study]5.6126752
GSM549133patient 032, cancer, homogenized [OPG study]8.9148187
GSM549139patient 042, cancer, homogenized [OPG study]8.4085584
GSM549099patient 107, normal, homogenized [OPG study]6.2194762
GSM549109patient 139, normal, homogenized [OPG study]5.6208652
GSM549110patient 046, normal, homogenized [OPG study]6.5094466
GSM549114patient 063, normal, homogenized [OPG study]6.3627264
GSM549122patient 082, normal, homogenized [OPG study]5.8436955
GSM549134patient 033, cancer, homogenized [OPG study]7.9780681
GSM549136patient 036, cancer, homogenized [OPG study]8.5253785
GSM549140patient 044, cancer, homogenized [OPG study]8.8298587
GSM549111patient 047, normal, homogenized [OPG study]6.7884369
GSM549113patient 057, normal, homogenized [OPG study]5.9992659
GSM549132patient 031, cancer, homogenized [OPG study]8.9863789
GSM549137patient 038, cancer, homogenized [OPG study]7.9895381
GSM549142patient 047, cancer, homogenized [OPG study]7.1543174
GSM549100patient 110, normal, homogenized [OPG study]6.164661
GSM549107patient 135, normal, homogenized [OPG study]6.3939364
GSM549115patient 068, normal, homogenized [OPG study]6.6334367
GSM549116patient 072, normal, homogenized [OPG study]6.6770567
GSM549120patient 078, normal, homogenized [OPG study]7.6797278
GSM549131patient 030, cancer, homogenized [OPG study]7.5001676
GSM549118patient 074, normal, homogenized [OPG study]5.9943558
GSM549129patient 027, cancer, homogenized [OPG study]7.1422872
GSM549123patient 088, normal, homogenized [OPG study]6.1719261
GSM549124patient 006, cancer, homogenized [OPG study]8.2256884
GSM549126patient 015, cancer, homogenized [OPG study]7.0206572
GSM549128patient 025, cancer, homogenized [OPG study]7.4301775
GSM549103patient 117, normal, homogenized [OPG study]4.8938637
GSM549117patient 073, normal, homogenized [OPG study]5.9638958
GSM549138patient 041, cancer, homogenized [OPG study]7.2747874
GSM549141patient 045, cancer, homogenized [OPG study]7.9951380
GSM549130patient 028, cancer, homogenized [OPG study]8.6796187
GSM549101patient 111, normal, homogenized [OPG study]5.2441144
GSM549105patient 128, normal, homogenized [OPG study]5.6315252
GSM549106patient 134, normal, homogenized [OPG study]3.609027
GSM549112patient 048, normal, homogenized [OPG study]6.1590261
GSM549125patient 011, cancer, homogenized [OPG study]8.4889486
GSM549127patient 024, cancer, homogenized [OPG study]5.6820453
GSM549135patient 035, cancer, homogenized [OPG study]8.5028684